ODDB.org: Open Drug Database

Swissmedic Registration	68626	Date of registration	11.01.2023
Company name	IBSA Institut Biochimique SA	Revision date
		Valid until	10.01.2028
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.10.60.	Information for professionals

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Condromed 200 mg / 250 mg	Hartkapseln	Capsules (Glucosamini Hydrochloridum 250 mg, Chondroitine Sodium Sulfate 200 mg)	M01CX

2025	©ywesee GmbH